19317075

Yu M

2009

[Clinical applications of anti-M?llerian hormone in evaluating ovarian reserve functions].

19318449

Puurunen J

2009

Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.

19318457

Iwase A

2009

Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN.

19322973

Sundararaman PG

2008

Psychosocial aspects of women with polycystic ovary syndrome from south India.

19324338

Xita N

2010

CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.

19324344

Kim CH

2010

Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome.

19327767

Xu N

2010

Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.

19328476

Zhang L

2010

Effects of testosterone and metformin on glucose metabolism in endometrium.

19329110

Martins WP

2009

Flow-mediated dilatation in polycystic ovary syndrome women.

19329515

Koulouri O

2009

Management of hirsutism.

19329517

Wiltgen D

2009

Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.

19330342

Kebapcilar L

2010

Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.

19330612

Artini PG

2009

Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.

19332438

Carel JC

2009

Consensus statement on the use of gonadotropin-releasing hormone analogs in children.

19337008

Yilmaz M

2009

Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.

19338206

Rudnicka E

2009

[Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome].

19338993

Di Fede G

2010

High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.

19338997

James S

2010

Increased secretion of amylin in women with polycystic ovary syndrome.

19340711

Pehlivanov B

2009

Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.

19341939

Camacho-Mart?nez FM

2009

Hair loss in women.

19342023

Tartagni M

2010

Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women.

19342030

Gurusinghe D

2010

In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.

19342032

Gonz?lez-Fern?ndez R

2010

FSH receptor, KL1/2, P450, and PAPP genes in granulosa-lutein cells from in vitro fertilization patients show a different expression pattern depending on the infertility diagnosis.

19342396

Carlsen SM

2009

Anti-M?llerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.

19344852

Pfeifer SM

2009

Polycystic ovary syndrome in the adolescent.

19345914

Narsing Rao L

2009

Effects of pioglitazone on menstrual frequency, hyperandrogenism and insulin resistance in adoloscents and young adults with polycystic ovary syndrome.

19345941

Yang HP

2009

Apnea-hypopnea index in nonobese women with polycystic ovary syndrome.

19346751

von Wolff M

2009

[Implantation: physiology, pathology and therapeutic options in disorders of implantation].

19347015

Loria P

2009

Endocrine and liver interaction: the role of endocrine pathways in NASH.

19347228

Spritzer PM

2009

[Etiological diagnosis of hirsutism and implications for the treatment].

19347703

Shah D

2009

Hirsutism.

19347705

Api M

2009

Is ovarian reserve diminished after laparoscopic ovarian drilling?

19347711

Espin?s-G?mez JJ

2009

Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome.

19349472

Legro RS

2009

Heirarchical clustering and beyond in PCOS endometrium: brave new world.

19349670

Gong F

2009

Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.

19350434

Ekback M

2009

It is always on my mind: women's experiences of their bodies when living with hirsutism.

19350748

Berlan ED

2009

Managing polycystic ovary syndrome in adolescent patients.

19351727

Kuijper EA

2009

Prevalence of polycystic ovary syndrome in women from opposite-sex twin pairs.

19351732

Blank SK

2009

Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.

19351735

Biyasheva A

2009

Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.

19352298

Karrer-Voegeli S

2009

Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.

19353333

Wiksten-Almstr?mer M

2009

Reduced bone mineral density in adult women diagnosed with menstrual disorders during adolescence.

19359152

Gambineri A

2009

Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome.

19361798

Desforges-Bullet V

2010

Increased anti-M?llerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.

19362300

Yang YJ

2009

Ultrastructure of human oocytes of different maturity stages and the alteration during in vitro maturation.

19362307

Verit FF

2009

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.

19362308

Kaya C

2010

C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome.

19362714

Api M

2009

Is there any difference among the most frequently used laparoscopic ovarian drilling techniques?

19362719

Georgopoulos NA

2009

Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.

19366845

Moro C

2009

Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.

19367058

Yavasoglu I

2009

Polycystic ovary syndrome and prolactinoma association.

19367587

Abbott DH

2009

Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys.

19368130

Baka S

2009

Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle.

19368509

Beydoun HA

2009

Impact of polycystic ovary syndrome on selected indicators of in vitro fertilization and intracytoplasmic sperm injection treatment success.

19368908

Huang S

2010

Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?

19368913

Adali E

2010

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.

19370293

Jammah AA

2009

Gestational diabetes after infertility treatment for polycystic ovarian syndrome.

19370625

Tso LO

2009

Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.

19373621

Kenna HA

2009

Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment.

19375561

Bates GW

2009

Discussion: 'Novel clomiphene protocol in polycystic ovarian syndrome' by Hurst et al.

19375576

Bates GW

2009

Novel clomiphene protocol in polycystic ovarian syndrome: Hurst et al.

19375579

Svendsen PF

2009

Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.

19375597

Glueck CJ

2009

Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.

19375763

Gonz?lez F

2009

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

19376510

Zhao SY

2010

Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome.

19380127

Ya?ar HY

2009

Clomiphene citrate-induced severe hypertriglyceridemia.

19380385

Thomson RL

2009

The effect of weight loss on anti-M?llerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.

19385377

Sueblinvong T

2009

Ovarian cancer: risks.

19387577

Pak SC

2009

Effect of Korean red ginseng extract in a steroid-induced polycystic ovary murine model.

19387820

Unsal T

2009

Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.

19388545

Meczekalski B

2009

[The role of inhibins in functions and dysfunctions of female reproduction. Part I].

19389110

Pinhas-Hamiel O

2009

Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS).

19389885

Cho LW

2009

The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.

19389897

Brown DL

2009

Ovarian stromal hyperthecosis: sonographic features and histologic associations.

19390322

Nisenblat V

2009

Androgens and polycystic ovary syndrome.

19390629

He W

2009

PPAR?2 polymorphism and human health.

19391530

Shi Y

2009

[Observation on therapeutic effect of acupuncture combined with chinese herbs on polycystic ovary syndrome of kidney deficiency and phlegm stasis type].

19392616

Hickey M

2009

Abnormal uterine bleeding: a focus on polycystic ovary syndrome.

19394000

Yildiz BO

2010

Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.

19394003

Cupisti S

2010

Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.

19394610

Kasa-Vubu JZ

2010

Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females.

19395966

Tamer Erel C

2009

The impact of body mass index on assisted reproduction.

19396538

Siebert TI

2009

Evaluating the equivalence of clomiphene citrate with and without metformin in ovulation induction in PCOS patients.

19400993

Lan VT

2009

Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.

19401323

Overbeek A

2009

Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.

19401328

Sathyapalan T

2009

Investigating hirsutism.

19401371

Urbanek M

2009

The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.

19401444

Mart?nez-Garc?a MA

2009

Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism.

19403562

Valkenburg O

2009

Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.

19405411

Radosh L

2009

Drug treatments for polycystic ovary syndrome.

19408173

Gen R

2009

Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.

19408174

Yilmaz M

2009

Serum resistin and adiponectin levels in women with polycystic ovary syndrome.

19409030

Haddad PM

2009

A review of valproate in psychiatric practice.

19409546

Zhu W

2010

Transvaginal ultrasound-guided ovarian interstitial laser treatment in anovulatory women with polycystic ovary syndrome: a randomized clinical trial on the effect of laser dose used on the outcome.

19409554

Livadas S

2010

The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome.

19413702

Diamanti-Kandarakis E

2009

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.

19414528

Tan BK

2009

Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.

19418980

Puder J

2009

[Polycystic ovary syndrome and insulin resistance].

19421925

Knebel B

2009

[Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].

19423104

Meldrum DR

2009

Adjuncts for ovarian stimulation: when do we adopt orphan indications for approved drugs?